Records 1 - 4
| Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis.
OncoTargets and therapy 2018 11 3495-3504.
Li Chunpu, Yu Xin, Guo Dongmei, Liu Guanhua, Zhang Kaigang, Teng Qingliang, Lin H
| Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
International journal of clinical and experimental pathology 2015 8 (7): 7905-12.
Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi
| Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 11652-7.
Wang M J, Zhu Y, Guo X J, Tian Z
| Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
The pharmacogenomics journal 2009 Oct 9 (5): 347-53.
Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira